CHEK2 and breast cancer: In previous cases with ATM/CHEK2 combination (all female), two presented only breast cancer (diagnosed at 39 and 60 years), one presented breast and bladder cancer (diagnosed at 53 and 58 years, respectively), and one patient presented colorectal cancer at 44 [8–10].